Join
Live feed
·
PRReleasevia Quantisnow
PDS Biotechnology Corporation logo

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

ByQuantisnow·Wall Street's wire, on your screen.
PDSB· PDS Biotechnology Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PDSB (PDS Biotechnology Corporation) and more on Quantisnow.